All In MedTech

Device Trial Radar · NCT02347189

Melody PB1016 Surveillance Study

Melody(TM) Transcatheter Pulmonary Valve PB1016 Surveillance Study Implantation of the Medtronic Melody Transcatheter Pulmonary Valve PB1016 Using the Ensemble(TM) Transcatheter Delivery System in Patients With Dysfunctional RVOT Conduits

Last checked: Nov 20, 2026Latest source record: Nov 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

39

Actual

Start

Nov 2014

Primary completion

Nov 2016

Study completion Aug 10, 2018

Sponsor

Lead sponsor
Medtronic Heart ValvesPublic (MDT)
Sponsor type
Industry
First posted
Jan 27, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Non-randomized, multi-center, prospective surveillance study to investigate and assess the residual risks, and to confirm the currently established safety and performance of the Melody TPV PB1016.

Conditions

  • Dysfunctional RVOT Conduits in Patients With Congenital Heart Defects

Interventions

  • Melody Transcatheter Pulmonary Valve PB1016Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects With Acceptable TPV Hemodynamic Function At 6 MonthsTime frame: 6 Months

Locations

8 sites in 4 countries. Site status is shown where the registry gives one.

  • University of California - Los Angeles

    Los Angeles, California

  • Children's Hospital of Michigan

    Detroit, Michigan

  • Nationwide Childrens Hospital

    Columbus, Ohio

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.